Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents– a real-world cross-sectional study from Switzerland (SAKK 95/16)

Table 3 BPI-SF pain scores according to BTA treatment and risk status^a

	Overall sample Receiving BTA Therapy		Known risk status Bone complication risk
	No (n = 104)	Yes (n = 296)	High (n = 229)	Low (n = 155)
BPI-SF Worst pain	n (%)	n (%)	n (%)	n (%)
No	31 (30)	81 (27)	64 (28.0)	43 (28)
Mild	53 (51)	121 (41)	97 (42.7)	71 (46)
Moderate	8 (8)	47 (16)	34 (14.5)	19 (12)
Severe	12 (11)	47 (16)	34 (14.5)	22 (14)

Note: Pain assessment was missing for 17 patients;
^a risk of bone complications was defined by the treating physician based on estimated risk for pathological fractures, surgery or radiation to bone, or spinal cord compression

ISSN: 1471-2407